EGFR and adenoma: We then sought to determine the influence of Anthos treatment on the Src- and EGFR-related pathways in an ETBF-treated ApcMin/+ mouse model, which have been reported to have increased EGFR activity and c-Src expression in the adenoma and intestinal enterocyte tissue [32].